Fend bottle in sky

Tough on Bugs. Gentle on You.

Non-oily, hypoallergenic insect repellent that protects for 14 hours.

Buy now

APVMA APPROVAL NUMBER 91808/133517

All-day protection.

With 14 hours clinically proven protection, Fend is Australia's longest-lasting DEET-free repellent.

Apply once and enjoy bite-free days and nights.

Get protected
Baby hand reaching for Fend

For the whole family.

Fend is kind to even the most sensitive skin.

It is suitable for babies 2 months and older, and for expecting or breastfeeding mothers.

See ingredients
Fend being applied to palm

Pleasant to use.

Fend offers a soft-touch finish that won't leave you feeling oily or sticky.

It's hypoallergenic with no overpowering or lingering scent.

Try it now
  • long-lasting protection
  • suitable for babies 2 months and up
  • non-oily
  • deet-free
  • hypoallergenic
  • pleasant feel and smell
Mother and child using Fend

How it works.

Fend uses an active ingredient called ethyl butylacetylaminopropionate.

It's hard to say, but it's a gentle amino acid that is friendly to skin and the environment.

On its own it is short-acting, so Fend uses extracts from algae and mushrooms to hold it in microscopic bubbles.

These bubbles release the active gradually over hours and keeping you protected for longer.

Buy Fend

Clinical studies

Inspired by nature. Backed by science.

Arm-in cage study: AEDES AEGYPTI

PARTICIPANTS: 10 participants - 4 women, 6 men - aged 18-60.

SPECIES: 55 female mosquitoes aged 5-10 days of species Aedes Aegypti.

RESULTS: 0 stings were recorded by 14 hours. Stings were recorded on 4 of the 10 participants at 15 hours.

CONCLUSION: Considered satisfactory for repellent action to mosquito species Aedes Aegypti during a period of 14 hours after application.

Arm-in cage study: AEDES ALBOPICTUS

PARTICIPANTS: 10 participants - 5 women, 5 men - aged 18-60.

SPECIES: 55 female mosquitoes aged 5-10 days of species Aedes Albopictus.

RESULTS: 0 stings were recorded by 13 hours. Stings were recorded on 3 of the 10 participants at 14 hours.

CONCLUSION: Considered satisfactory for repellent action to mosquito species Aedes Albopictus during a period of 13 hours after application.

Arm-in cage study: CULEX QUINQUEFASCIATUS

PARTICIPANTS: 10 participants - 5 women, 5 men - aged 18-60.

SPECIES: 55 female mosquitoes aged 5-10 days of species Culex Quinquefasciatus.

RESULTS: 0 stings were recorded by 14 hours. Stings were recorded on 3 of the 10 participants at 15 hours.

CONCLUSION: Considered satisfactory for repellent action to mosquito species Culex Quinquefasciatus during a period of 14 hours after application.

Arm-in cage study: ANOPHELES AQUASALIS

PARTICIPANTS: 10 participants - 6 women, 4 men - aged 18-60.

SPECIES: 55 female mosquitoes aged 5-10 days of species Anopheles Aquasalis.

RESULTS: 0 stings were recorded by 13 hours. Stings were recorded on 4 of the 10 participants at 14 hours.

CONCLUSION: Considered satisfactory for repellent action to mosquito species Anopheles Aquasalis during a period of 13 hours after application.

Dermal Irritability

OBJECTIVE: To evaluate the potential of adverse skin reactions caused by topical use.

PARTICIPANTS: 54 participants - 43 women, 11 men - aged 19-63.

METHODOLOGY: The repellent was applied to hypoallergenic adhesive strips. Strips were applies to the same location on participants 3 times per week for 3 weeks.

RESULTS: No side effects (erythema, edema, papule or vesicle) were detected in the area of application, and no participants reported sensations of discomfort during the study.

CONCLUSION: A primary irritation index of 0.0 out of a possible 8.0 at is sufficient to classify the repellent as 'Toxicity Category IV - Very Low Toxicity'.

Photosensitisation

OBJECTIVE: To evaluate the potential of adverse skin reactions caused by exposure to UV light following topical use.

PARTICIPANTS: 35 participants - 28 women, 7 men - aged 18-63.

METHODOLOGY: The repellent was applied to hypoallergenic adhesive strips. Strips were applied to participants for 24 hours. When removed, the test area was immediately exposed to 4 J/cm2 UVA light to test for discomfort or clinical reactions. Tests were repeated on the same area 3 times per week for 2 weeks.

RESULTS: No side effects (erythema, edema, papule or vesicle) were detected in the area of application.

CONCLUSION: The product did not cause photosensitisation and was not shown to be phototoxic and support the 'hypoallergenic' appeal.